ICH Project ICH S1B (R1) Guideline Information Session
Nov 28, 2023
The ICH S1B(R1) Guideline reached Step 4 on August 4, 2022, based on the review by the ICH S1B(R1) Expert Working Group, and the "Revision of Guidelines for Carcinogenicity Studies of Drugs" including the revision of the ICH S1B(R1) Guideline was issued in Japan on March 10, 2023. The revision of the guideline was issued as a notice on March 10, 2023, and has reached Step 5 in Japan.
The ICH S1B(R1) Guideline Information Session was held to promote understanding of the guideline.
The program and other details of the briefing can be found on the PMDA Website.
The End